8431
On July 16th, 2019 Part 6 of Article 13 of the Law of Ukraine “On Ensuring Functioning Ukrainian as State Language” comes into force. This entails changes in the official paperwork for the pharmaceutical market. Lawyers of Legal Alliance Company analyzed the situation and found options for a legal way out of the situation in the preparation of certificates for medicines.
4348
Dmytro Aleshko took part in the conference “Poland-Ukraine: Medicine and Biotechnology” held by the Polish community on occasion of 20-year anniversary of the International Community of Polish Entrepreneurs of Ukraine. In his speech Mr. Aleshko drew attention of the participants to regulation of market of medicines and medical devices in Ukraine, and also related prospects for Ukrainian and foreign business.
5281
On May 31, 2019, two draft orders concerning the introduction of reference pricing of medicines were published on the website of the Ministry of Health of Ukrai
5134
On May 27th, 2019 Resolution of the Cabinet of Ministers of Ukraine “On Reference Pricing for Medicines Procured for Budgetary Funds” No. 426 as of April 3rd, 2
4616
On May 21st Resolution of the Cabinet of Ministers of Ukraine “On Amending Some Resolutions of the Cabinet of Ministers of Ukraine” (hereinafter – draft resolut
14083
No. 17/18 (1188/1189) May 13th, 2019 р. As we know, from July 1st, 2019 is it planned to introduce reference pricing for some medicines from the National List
5139
On April 9, the Ministry of Health of Ukraine published a draft order on certain issues of reference pricing for medicines included in the National List of Essential Medicines and procured using budget funds
9124
Apteka.ua, No. 13 (1184), 8 April 2019 Since April 1st, 2019 within the government program “Affordable Medicines” medicines have been released based on elect
5688
On March 20th, 2019 the Ministry of Health put the revised draft resolution of the Cabinet of Ministers of Ukraine “On Reference Pricing for Some Medicines Procured for Budget Funds” on public discussion
9041
The medical reform and its influence on the pharmaceutical industry and prospects of the market development were discussed at the Ukrainian Pharmaceutical Congress
